Gestion des agents antiplaquettaires en cas de procédure invasive non programmée ou d’hémorragie. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie et de réanimation (SFAR)

Patrono, 2017, Antiplatelet agents for the treatment and prevention of coronary atherothrombosis, J Am Coll Cardiol, 70, 1760, 10.1016/j.jacc.2017.08.037 Nagelschmitz, 2014, Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers, Clin Pharmacol, 6, 51 Floyd, 2012, Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications, Clinical Pharmacokinetics, 51, 429, 10.2165/11630740-000000000-00000 Rossini, 2018, A multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2, JACC Cardiovasc Interv, 11, 417, 10.1016/j.jcin.2017.10.051 Larsen, 2017, Predictive value of whole blood and plasma coagulation tests for intra- and postoperative bleeding risk: a systematic review, Semin Thromb Hemost, 43, 772, 10.1055/s-0037-1602665 Jahn, 2017, Effect of clopidogrel on thrombus formation in an ex vivo parallel plate flow chamber model cannot be reversed by addition of platelet concentrates or vWF concentrate, Anesth Analg, 124, 1091, 10.1213/ANE.0000000000001903 Li, 2017, Microfluidic whole blood testing of platelet response to pharmacological agents, Platelets, 28, 457, 10.1080/09537104.2016.1268254 Prüller, 2017, Implementation of buffy-coat-derived pooled platelet concentrates for internal quality control of light transmission aggregometry: a proof of concept study, J Thromb Haemost, 15, 2443, 10.1111/jth.13870 Le Quellec, 2016, Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literature, Thromb Haemost, 116, 638, 10.1160/TH15-11-0870 Kozek-Langenecker, 2017, Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016, Eur J Anaesthesiol, 34, 332, 10.1097/EJA.0000000000000630 Price, 2011, Standard- vs. high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial, JAMA, 305, 1097, 10.1001/jama.2011.290 Breet, 2010, Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation, JAMA, 303, 754, 10.1001/jama.2010.181 Collet, 2012, Bedside monitoring to adjust antiplatelet therapy for coronary stenting, N Engl J Med, 367, 2100, 10.1056/NEJMoa1209979 Hansson, 2017, Antiplatelet therapy, platelet function testing, and bleeding complications in cardiac surgery patients, Semin Thromb Hemost, 43, 699, 10.1055/s-0037-1603366 Kwak, 2010, Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery, J Am Coll Cardiol, 56, 1994, 10.1016/j.jacc.2010.03.108 Preisman, 2010, Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery, Eur J Cardiothorac Surg, 37, 1367, 10.1016/j.ejcts.2009.12.044 Alström, 2009, Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery, Thrombosis Res, 124, 572, 10.1016/j.thromres.2009.06.024 Malm, 2016, Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study, Br J Anaesth, 117, 309, 10.1093/bja/aew189 Ranucci, 2011, Multiple electrode whole blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines, Ann Thorac Surg, 91, 123, 10.1016/j.athoracsur.2010.09.022 Mahla, 2018, Platelet inhibition and bleeding in patients undergoing non-cardiac surgery – The BIANCA Observational Study, Thromb Haemost, 10.1055/s-0038-1641153 Kirmani, 2017, Platelet function testing in cardiac surgery: a comparative study of electrical impedance aggregometry and thromboelastography, Platelets, 28, 550, 10.1080/09537104.2016.1237626 Godier, 2018, Arch Cardiovasc Dis Authors/Task Force Members, 2014, Eur Heart J, 35, 2541, 10.1093/eurheartj/ehu283 Hansson, 2017, Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery, Eur J Cardiothorac Surg, 51, 633 Alexopoulos, 2014, Ticagrelor vs. prasugrel one-month maintenance therapy: impact on platelet reactivity and bleeding events, Thromb Haemost, 112, 551, 10.1160/TH14-02-0119 Armstrong, 2017, Newly formed reticulated platelets undermine pharmacokinetically short-lived antiplatelet therapies, Arterioscler Thromb Vasc Biol, 37, 949, 10.1161/ATVBAHA.116.308763 Lordkipanidze, 2012, Aspirin twice a day keeps new COX-1 at bay, J Thromb Haemost, 10, 1217, 10.1111/j.1538-7836.2012.04764.x Mazzeffi, 2017, Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitors, Korean J Anesthesiol, 70, 379, 10.4097/kjae.2017.70.4.379 Mahla, 2015, Platelet function testing before cabg is recommended in the guidelines: but do we have enough evidence?, J Interv Cardiol, 28, 233, 10.1111/joic.12194 Grove, 2013, Platelet function testing and prediction of procedural bleeding risk, Thromb Haemost, 109, 817, 10.1160/TH12-11-0806 Tantry, 2013, Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding, J Am Coll Cardiol, 62, 2261, 10.1016/j.jacc.2013.07.101 Berger, 2015, Does preoperative platelet function predict bleeding in patients undergoing off-pump coronary artery bypass surgery?, J Interv Cardiol, 28, 223, 10.1111/joic.12200 Vries, 2017, Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients, Eur Heart J Cardiovasc Pharmacother, 3, 11, 10.1093/ehjcvp/pvw026 Morici, 2013, Time from adenosine diphosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: meta-analysis and meta-regression, Int J Cardiol, 168, 1955, 10.1016/j.ijcard.2012.12.087 Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482 Held, 2011, Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial, J Am Coll Cardiol, 57, 672, 10.1016/j.jacc.2010.10.029 Mahla, 2012, Circ Cardiovasc Interv, 5, 261, 10.1161/CIRCINTERVENTIONS.111.967208 Bobbitt, 2018, Evaluating the effectiveness of preoperative platelet inhibition testing to reduce costs and preoperative length of stay, Appl Nurs Res, 39, 241, 10.1016/j.apnr.2017.11.029 Ferraris, 2012, 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations, Ann Thorac Surg, 94, 1761, 10.1016/j.athoracsur.2012.07.086 Valgimigli, 2018, Eur Heart J, 39, 213, 10.1093/eurheartj/ehx419 Bonhomme, 2016, [The role of point-of-care platelet function testing in guiding platelet transfusion], Transfus Clin Biol, 23, 202, 10.1016/j.tracli.2016.08.001 Chen, 2004, Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting, J Thorac Cardiovasc Surg, 128, 425, 10.1016/j.jtcvs.2004.02.019 Görlinger, 2011, First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study, Anesthesiology, 115, 1179, 10.1097/ALN.0b013e31823497dd Weber, 2012, Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients, Anesthesiology, 117, 531, 10.1097/ALN.0b013e318264c644 Corredor, 2015, The role of point-of-care platelet function testing in predicting postoperative bleeding following cardiac surgery: a systematic review and meta-analysis, Anaesthesia, 70, 715, 10.1111/anae.13083 Li, 2013, Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage, J Neurosurg, 118, 94, 10.3171/2012.9.JNS112286 Bartoszko, 2017, Can predicting transfusion in cardiac surgery help patients?, Br J Anaesth, 119, 350, 10.1093/bja/aex216 Biancari, 2018, External validation of the WILL-BLEED Risk Score, Thromb Haemost, 118, 433, 10.1160/TH17-10-0702 Olechowski, 2017, Changes in platelet function with inflammation in patients undergoing vascular surgery, Platelets, 1 HAS, 2015, 1 ANSM, 2012, 1 Rossaint, 2016, The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition, Crit Care, 20, 100, 10.1186/s13054-016-1265-x Li, 2012, Reversal of the antiplatelet effects of aspirin and clopidogrel, J Thromb Haemost, 10, 521, 10.1111/j.1538-7836.2012.04641.x Hansson, 2014, Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor, Br J Anaesth, 112, 570, 10.1093/bja/aet339 Taylor, 2013, Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery?, J Trauma Acute Care Surg, 74, 1367, 10.1097/01586154-201305000-00027 Vilahur, 2007, Normalization of platelet reactivity in clopidogrel-treated subjects, J Thromb Haemost, 5, 82, 10.1111/j.1538-7836.2006.02245.x O’Connor, 2015, Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study, Circ Cardiovasc Interv, 8, e002786, 10.1161/CIRCINTERVENTIONS.115.002786 Schoener, 2017, Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue, Clin Res Cardiol, 106, 868, 10.1007/s00392-017-1128-8 Zafar, 2013, Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation, J Thromb Haemost, 11, 100, 10.1111/jth.12058 Bonhomme, 2015, Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: an ex vivo study, Platelets, 26, 324, 10.3109/09537104.2015.1035247 Bertling, 2018, Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor, J Thromb Haemost, 10.1111/jth.14014 Dobesh, 2014, Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety, Pharmacotherapy, 34, 1077, 10.1002/phar.1477 Ferri, 2013, Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties, Drugs, 73, 1681, 10.1007/s40265-013-0126-z Martin, 2016, The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation, Eur J Anaesthesiol, 33, 361, 10.1097/EJA.0000000000000348 Godier, 2015, Inefficacy of platelet transfusion to reverse ticagrelor, N Engl J Med, 372, 196, 10.1056/NEJMc1409373 Zafar, 2017, Impact of timing on the functional recovery achieved with platelet supplementation after treatment with ticagrelor, Circ Cardiovasc Interv, 10, e005120, 10.1161/CIRCINTERVENTIONS.117.005120 Levi, 2011, Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents, J Thromb Haemost, 9, 1705, 10.1111/j.1538-7836.2011.04432.x Ghadimi, 2016, Perioperative management of the bleeding patient, Br J Anaesth, 117, 10.1093/bja/aew358 Martin, 2017, [Management of the bleeding risk associated with antiplatelet agents], Rev Med Interne, 38, 467, 10.1016/j.revmed.2017.01.013 Colucci, 2014, The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects, Blood, 123, 1905, 10.1182/blood-2013-04-497123 Orsini, 2017, Bleeding risk of surgery and its prevention in patients with inherited platelet disorders, Haematologica, 102, 1192, 10.3324/haematol.2016.160754 Mannucci, 1997, Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years, Blood, 90, 2515, 10.1182/blood.V90.7.2515 Mannucci, 1988, Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders, Blood, 72, 1449, 10.1182/blood.V72.5.1449.1449 Reiter, 2003, Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin, Blood, 102, 4594, 10.1182/blood-2002-11-3566 Ranucci, 2007, Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy, J Cardiothorac Vasc Anesth, 21, 851, 10.1053/j.jvca.2007.05.009 Desborough, 2017, Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials, J Thromb Haemost, 15, 263, 10.1111/jth.13576 Altun, 2017, Emergency coronary bypass surgery in patients under the influence of dual antiplatelet therapy: effects of tranexamic acid and desmopressin acetate, Turk J Med Sci, 47 Bonhomme, 2018, Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: a randomised, placebo-controlled study in a rabbit model, Eur J Anaesth, 35, 208, 10.1097/EJA.0000000000000775 Teng, 2014, The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor, J Clin Pharm Ther, 39, 186, 10.1111/jcpt.12130 Frontera, 2016, Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine, Neurocrit Care, 24, 6, 10.1007/s12028-015-0222-x Leissinger, 2014, Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders, Haemophilia, 20, 158, 10.1111/hae.12254 Godier, 2018, Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH, J Thromb Haemost, 16, 170, 10.1111/jth.13893 Altman, 2006, Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation, J Thromb Haemost, 4, 2022, 10.1111/j.1538-7836.2006.02088.x Mazzeffi, 2013, In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel, Thromb Res, 132, 106, 10.1016/j.thromres.2013.04.007 Skolnick, 2011, Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects, Anesth Analg, 1 Pehrsson, 2016, Boosting the coagulation restores haemostasis in ticagrelor-treated mice, Blood Coagul Fibrinolysis, 27, 913, 10.1097/MBC.0000000000000511 EMEA. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001241/WC500100494.pdf [n.d.]. Hindy-François, 2010, Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrel, Thromb Haemost, 104, 823, 10.1160/TH10-01-0039 Buchanan, 2015, Structural and functional characterization of a specific antidote for ticagrelor, Blood, 125, 3484, 10.1182/blood-2015-01-622928 Ker, 2012, Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis, BMJ, 344, e3054, 10.1136/bmj.e3054 Duranteau, 2015, Recommandations sur la réanimation du choc hémorragique, Anesth Reanim, 1, 62 http://www.ncepod.org.uk/classification.html [n.d.]. Graham, 2018, Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery, Ann Intern Med, 168, 237, 10.7326/M17-2341 Oscarsson, 2010, To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial, Br J Anaesth, 104, 305, 10.1093/bja/aeq003 Mantz, 2011, Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial, Br J Anaesth, 107, 899, 10.1093/bja/aer274 Rossini, 2014, Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies, EuroIntervention, 10, 38, 10.4244/EIJV10I1A8 B. Joseph, 2015, An acute care surgery dilemma: emergent laparoscopic cholecystectomy in patients on aspirin therapy, Am J Surg, 209, 689, 10.1016/j.amjsurg.2014.04.014 CAPRIE Steering Committee, 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee, Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Chu, 2016, The evaluation of clopidogrel use in perioperative general surgery patients: a prospective randomized controlled trial, Am J Surg, 211, 1019, 10.1016/j.amjsurg.2015.05.036 Columbo, 2018, A meta-analysis of the impact of aspirin, clopidogrel, and dual antiplatelet therapy on bleeding complications in noncardiac surgery, Ann Surg, 267, 1, 10.1097/SLA.0000000000002279 Soo, 2016, Clopidogrel and hip fractures, is it safe? A systematic review and meta-analysis, BMC Musculoskelet Disord, 17, 136, 10.1186/s12891-016-0988-9 Zehir, 2015, Early surgery is feasible in patients with hip fractures who are on clopidogrel therapy, Acta Orthop Traumatol Turc, 49, 249 Benahmed, 2014, Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study, Nephrol Dial Transplant, 29, 463, 10.1093/ndt/gft385 Pearcy, 2017, Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy, Am J Surg, 214, 1012, 10.1016/j.amjsurg.2017.08.035 Chemtob, 2017, Outcome after surgery for acute aortic dissection – influence of preoperative antiplatelet therapy on prognosis, J Cardiothorac Vasc Anesth, 31, 569, 10.1053/j.jvca.2016.10.007 Lee, 2017, Preoperative low-dose aspirin exposure and outcomes after emergency neurosurgery for traumatic intracranial hemorrhage in elderly patients, Anesth Analg, 125, 514, 10.1213/ANE.0000000000002053 Baschin, 2017, Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage, Vox Sang, 112, 535, 10.1111/vox.12542 Thiele, 2012, Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study, J Thromb Haemost, 10, 968, 10.1111/j.1538-7836.2012.04699.x Albaladejo, 2011, Non-cardiac surgery in patients with coronary stents: the RECO study, Heart, 97, 1566, 10.1136/hrt.2011.224519 Cornet, 2007, Coronary stent occlusion after platelet transfusion: a case series, J Invasive Cardiol, 19, E297 Myles, 2017, Tranexamic acid in patients undergoing coronary artery surgery, N Engl J Med, 376, 136, 10.1056/NEJMoa1606424 CRASH-2 trial collaborators, 2010, Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial, Lancet, 376, 23, 10.1016/S0140-6736(10)60835-5 Mahmoud, 2016, Perioperative cardiovascular risk of prior coronary stent implantation among patients undergoing noncardiac surgery, J Am Coll Cardiol, 67, 1038, 10.1016/j.jacc.2015.11.063 Mehran, 2013, Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study, Lancet, 382, 1714, 10.1016/S0140-6736(13)61720-1 Jaben, 2014, Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage, J Intensive Care Med, 30, 3, 10.1177/0885066613487298 Inohara, 2018, Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs. vitamin K antagonist oral anticoagulants with in-hospital mortality, JAMA, 319, 463, 10.1001/jama.2017.21917 Kobayashi, 2017, Novel oral anticoagulants and trauma: the results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial, J Trauma Acute Care Surg, 82, 827, 10.1097/TA.0000000000001414 Naidech, 2011, Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage, Neurocrit Care, 16, 82, 10.1007/s12028-011-9619-3 Leong, 2015, Is platelet transfusion effective in patients taking antiplatelet agents who suffer an intracranial hemorrhage?, J Emerg Med, 49, 561, 10.1016/j.jemermed.2015.02.023 Baharoglu, 2016, Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial, Lancet, 387, 2605, 10.1016/S0140-6736(16)30392-0 Arnone, 2018, Impact of platelet transfusion on intracerebral hemorrhage (ICH) in patients on antiplatelet therapy – An analysis based on ICH score, World Neurosurgery, 10.1016/j.wneu.2018.01.006 Oakland, 2017, Re-bleeding and mortality after lower gastrointestinal bleeding in patients taking antiplatelets or anticoagulants, Clin Gastroenterol Hepatol, S1542-3565 Zakko, 2017, No benefit from platelet transfusion for gastrointestinal bleeding in patients taking antiplatelet agents, Clin Gastroenterol Hepatol, 15, 46, 10.1016/j.cgh.2016.07.017 ASGE Standards of Practice Committee, 2016, The management of antithrombotic agents for patients undergoing GI endoscopy, Gastrointest Endosc, 83, 3, 10.1016/j.gie.2015.09.035 Makris, 2013, Guideline on the management of bleeding in patients on antithrombotic agents, Br J Haematol, 160, 35, 10.1111/bjh.12107